Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06827184

By Assessing the Continuous Respiratory Physiological Changes Through Prone Position, Determine the Optimal Duration for Prone Position

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The prone position leads to a more homogeneous distribution of ventilation by inflation of collapsed alveoli and reduction in alveolar hyperinflation. By employing EIT, the study can obtain a thorough comprehension of the ongoing alterations in regional ventilation before and after adopting the prone position. It is also anticipated that there is an impact on inflammation biomarkers before and after the prone position. This assessment aids in determining the ideal duration for prone position therapy, encompassing the necessary hours and days in the prone position.

Detailed description

The prone position leads to a more homogeneous distribution of ventilation by inflation of collapsed alveoli and reduction in alveolar hyperinflation. By employing EIT, the study can obtain a thorough comprehension of the ongoing alterations in regional ventilation before and after adopting the prone position. It is also anticipated that there is an impact on inflammation biomarkers before and after the prone position. This assessment aids in determining the ideal duration for prone position therapy, encompassing the necessary hours and days in the prone position. Therefore, the investigators propose a project with the aim of collecting relevant clinical, laboratory, imaging, and respiratory physiology data from consenting patients with ARDS within the study period. The objective is to analyze changes in biomarkers following prone position.

Conditions

Interventions

TypeNameDescription
DEVICEElectrical Impedance TomographyIt utilizes electrical impedance tomography to analyze a series of physiological changes in the lungs following treatment

Timeline

Start date
2024-09-20
Primary completion
2030-08-31
Completion
2030-12-31
First posted
2025-02-14
Last updated
2025-02-19

Locations

1 site across 1 country: Taiwan

Regulatory

Source: ClinicalTrials.gov record NCT06827184. Inclusion in this directory is not an endorsement.